R. Stoop
|
|
- 42
Gaissmaier C, Fritz J, Schewe B, Albrecht D, Weise K, Stoop R, Fink U, Giordano N, Ashammakhi N, Aicher WK. Development of NOVOCART®3D, a novel system for scaffold augmented transplantation of autologous chondrocytes. In: Basic Science, Clinical Repair and Reconstruction of Articular Cartilage Defects: Current Status and Prospects. Zanasi, M. Brittberg, S. Neher, M. Marcacci, R. Cancedda (Eds.). (In press).
- 41
Stoop R, Sapei L, Gaissmaier C, Scharstuhl A, Kellomäki M, Ellä V, Ashammakhi N, Törmälä P, Hämmerle H. Evaluation of PLDLA Scaffolds for Cartilage Tissue Engineering. 15th Interdisciplinary Research Conference on Biomaterials (GRIBOI 2005), Shanghai, China, 18-20.3.2005.
- 40
Stoop R, Sapei L, Gaissmaier C, Scharstuhl A, Kellomäki M, Ellä V, Ashammakhi N, Törmälä P, Hämmerle H. Investigation of PLDLA Scaffolds for Cartilage TE. University of Oulu Faculty of Medicine Science Day, Oulu, Finland, February 22, 2005. P-28.
|
|
- 39
Gründer T, Gaissmaier Ch, Fritz J, Stoop R, Hortschansky P, Mollenhauer JJ, Aicher WK. Bone morphogenetic protein (BMP)-2 enhances the expression of type II collagen and aggrecan in chondrocytes embedded in alginate beads. Osteoarthritis and Cartilage (Accepted).
- 38
Fritz J, Schneider U, Stoop R, Fink U, Weise K, Gaissmaier C. Die SCID-Maus als Tiermodell zur Evaluierung von Biomaterialien für die Transplantation chondrogener Zellen. 26. Münchner Symposion für experimentelle Ortopädie, 2004.
- 37
Stoop R, Schewe B, Fink U, Gründe, T, Weise K. Implantation humaner artikulärer Chondrozyten in die SCID-Maus: histologischer Ergebnisse mit unterschiedlichen kollagenen Trägermaterialien und Fibrinkleber. 26. Münchner Symposion für experimentelle Ortopädie, 2004.
- 36
Gründer T, Thunemann B, Keimer D, Gaissmaier Ch, Fritz J, Stoop R, Aicher WK. Wirkung von BMP-2 auf den Phänotyp von humanen Chondrozyten auf Monolayer und in einem 3D-Zellkultursystem. 26. Münchner Symposion für experimentelle Ortopädie, 2004.
- 35
Stoop R, Sapei L, Gaissmaier C, Scharstuhl A, Kellomäki M, Ellä V, Ashammakhi N, Törmälä P, Hämmerle H. Study of Woven P(L/D)LA Scaffolds for Cartilage Tissue Engineering. II Iberian Congress on Biomaterials (BIOÉvora2004), Évora, Portugal, 9-11.9.2004.
- 34
Stoop R, Sapei L, Gaissmaier C, Scharstuhl A, Kellomäki M, Ellä V, Ashammakhi N, Törmälä P, Hämmerle H. The Development of Woven P(L/D)LA Scaffolds for Cartilage Tissue Engineering. European Cells & Materials (ECM) V: The Cell Biomaterial Reaction, Davos, Switzerland, 28-30.6.2004.
- 33
Stoop R, Sapei L, Gaissmaier C, Scharstuhl A, Kellomäki M, Ellä V, Ashammakhi N, Törmälä P, Hämmerle H. Cartilage Tissue Engineering Using Chondrocytes and Woven P(L/D)LA Scaffolds. 5th ANNUAL SEMINAR OF “TISSUE ENGINEERING AND MEDICAL, DENTAL AND VETERINARY BIOMATERIAL RESEARCH GROUP (BRG)”, Biomedicum, Helsinki, Finland, June 1st, 2004.
- 32
Steinbach K, Gaissmaier C, Fritz J, Aicher W.K, Stoop
R: Isolation and expansion of human articular chondrocytes
in monolayer culture induces a proinflammatory cytokine
profile. European Cells and Materials (In press).
|
|
- 31
Stoop R, Sapei L, Gaissmaier C, Scharstuhl A, Kellomäki M, Ellä V, Ashammakhi N, Törmälä P, Hämmrele H. The Development of Woven P(L/D)LA Scaffolds for Cartilage Tissue Engineering. 18th European Conference on Biomaterials, October 1-4, 2003, Stuttgart, Germany, Proceedings
LMP037.
- 30
Gal I, Lesley J, Ko W, Gonda A, Stoop R, Hyman R,
Mikecz K: Role of the extracellular and cytoplasmic
domains of CD44 in the rolling interaction of lymphoid
cells with hyaluronan under physiologic flow. J Biol
Chem 278(13):11150-8, 2003.
|
|
- 29
Stoop R, Gal I, Glant T.T, McNeish J.D, Mikecz K:
Trafficking of CD44-deficient lymphocytes under normal
conditions and in inflammatory disease. Eur J Imm
32:2532-2542, 2002.
- 28
van Beuningen H.M, Stoop R, Buma P, van der Kraan
P.M, van den Berg W.B: Phenotypic differences in murine
chondrocyte cell lines derived from mature articular
cartilage. Osteoarthr Cart, 10(12):977-86, 2002.
|
|
- 27
Stoop R, Kotani H, McNeish J.D, Otterness I.G, Mikecz
K: CD44-deficient DBA/1 mice display increased resistance
to collagen-induced arthritis. Arthr Rheum, 14(12):
2922-2931, 2001.
- 26
van der Kraan P.M, Stoop R, Meijers T.H.M, Poole A.R,
van den Berg W.B: Expression of collagen type X in
young and old C57/Bl6 and BALB/c mice. Relation with
articular cartilage degeneration. Osteoarthr Cart
9(2):92-100, 2001.
- 25
Stoop
R, Buma P, van der Kraan P.M, Hollander A.P, Billinghurst
R.C, Meijers T.H.M, Poole A.R, van den Berg W.B: Type
II collagen degradation in articular cartilage fibrillation
after anterior cruciate ligament transection in rats.
Osteoarthr Cart. 9(4):308-15, 2001
- 24
Stoop R, McNeish J.D, Kotani H, Griffith R.J, Otterness
I.G, Glant T.T, Mikecz K: CD44-deficient DBA/1 mice
display alterations in leukocyte trafficking and increased
resistance to collagen-induced arthritis. Proceedings
of 47th meeting of the Orthopaedic Research society,
februari 25-28, 2001.
- 23
Stoop R, Buma P, van der Kraan P.M, Billinghurst R.C,
Hollander A.P, Poole A.R, van den Berg W.B: Type II
collagen degradation after anterior cruciate ligament
transection in the rat. Proceedings of 47th meeting
of the Orthopaedic Research society, februari 25-28,
2001.
- 22
Stoop R, Gal I, Glant T.T, McNeish J.D, Mikecz K:
Trafficking of CD44-deficient lymphocytes in normal
and inflammatory conditions in arthritis-susceptible
DBA/1 mice. Proceedings of the 65th Annual meeting
of the American College of Rheumatology, November
11-15, 2001, San Francisco. Arthr Rheum 44(9):s1466,
2001.
|
|
- 21
Cornelissen A.M.H, Stoop R, Von den Hoff J.W, Maltha
J.C, Kuijpers-Jagtman A.M: Myofibroblasts and matrix
components in healing palatal wounds in the rat. J
Oral Pathol Med 29(1):1-7, 2000.
- 20
Stoop
R, Buma P, van der Kraan P.M, Hollander A.P, Billinghurst
R.C, Poole A.R, van den Berg W.B: Differences in type
II collagen degradation between peripheral and central
cartilage of rat stifle joints after cranial cruciate
ligament transection.Arthr Rheum 43(9):2121-2139,
2000.
- 19
Buma P, Stoop R, Billinghurst C, Hollander A, Poole
A.R, van den Berg W.B: Type II collagen degradation
after anterior cruciate ligament transection in the
rat. Transaction of the 10th European Orthopaedic
Research Society, Oct 13-15, 2000, Wiesbaden.
- 18
Bardos T, Kamath R.V, Stoop R, Finnegan A., Mikecz
K, Glant T.T: Proteoglycan-induced progressive polyarthritis
of BALB/c mice can be adoptively transferred to SCID
mice, but requires antigen challenge. Proceedings
of the 64rd Annual meeting of the American College
of Rheumatology, October 29-November 2, 2000, Philadelphia.
Arthr Rheum 43(9):s75, 2000.
- 17
Stoop R, McNeish J.D, Kotani H, Griffith R.J, Otterness
I.G, Otto J.M, Glant T.T, Mikecz K: Reduction of incidence
and severity of collagen-induced arthritis in CD44-deficient
DBA/1 mice. Proceedings of the 64th Annual meeting
of the American College of Rheumatology, October 29-November
2, 2000, Philadelphia. Arthr Rheum 43(9):s386, 2000.
|
|
- 16
Stoop R, van der Kraan P.M, Buma P, Hollander A.P,
Poole A.R, van den Berg W.B: Denaturation of type
II collagen in articular cartilage in experimental
murine arthritis. Evidence for collagen degradation
in both reversible and irreversible cartilage damage.
J Path 188(3):329-337, 1999.
- 15
van Meurs J.B.J, van Lent P.L.E.M, Stoop R, Holthuysen
A.E.M, Singer I.I, Bayne E.K, Mudgett J.S, Poole,
A.R, Billinghurst R.C, van der Kraan P.M, Buma P,
van den Berg W.B. Cleavage of aggrecan at ASN341-PHE342
site coincides with the initiation of collagen damage
in murine antigen induced arthritis. A pivotal role
for stromelysin-1 in MMP-activity. Arthr Rheum. 42(10):2074-2084,
1999.
- 14
Stoop R, van der Kraan P.M, Buma P, Poole A.R, Billinghurst
R.C, Hollander A.P, van den Berg W.B. Type II collagen
degradation is restricted to lesion sites in spontaneous
osteoarthritis in C57bl/6 and Balb/c mice. Arthr Rheum.,
42(11):2381-2389, 1999.
- 13
Stoop R, van der Kraan P.M, Buma P, Poole A.R, Billinghurst
R.C, Hollander A.P, van den Berg W.B: Type II collagen
degradation is restricted to lesion sites in spontaneous
osteoarthritis in C57bl/6 and BALB/c mice. Proceedings
of 45rd meeting of the Orthopaedic Research society,
februari 1-4, 1999, Anaheim.45:39, 1999
- 12
Stoop R, van der Kraan P.M, Buma P, Billinghurst R.C,
Hollander A.P, Poole A.R, van den Berg W.B: Type II
collagen degradation is restricted to lesion sites
in spontaneous osteoarthritis in C57bl/6 and BALB/c
mice. Proceedings of the fourth World Congress on
Osteoarthritis, September 16-19, 1999. Osteoarthr
Cart 8(2):148-149, 1999
- 11
Stoop R, van der Kraan P.M, Billinghurst R.C, Hollander,
A.P. Poole A.R, van den Berg W.B: Type II collagen
degradation after anterior cruciate ligament transection
in the rat. Proceedings of the 63rd Annual meeting
of the American College of Rheumatology, November
13-17, 1999, Boston. Arthr Rheum.:42(9):s257, 1999.
|
|
- 10
van Meurs J.B.J, van Lent P.L.E.M, Holthuysen A.E.M,
Stoop R, Singer I.I, Bayne E.K, van den Berg W.B:
Expression of aggrecanase and metalloproteinase induced
neoepitopes in different murine models of arthritis.
Proceedings of 44rd meeting of the Orthopaedic Research
society, march 16-19, 1998, New Orleans. 44:21,1998
- 9
Stoop R, van Meurs J.B.J, Singer I.I, Bayne E.K, Poole
A.R, Billinghurst R.C, Buma P, van Lent P.L.E.M, van
der Kraan P.M, and van den Berg W.B: The collagenase
cleavage site in type II collagen colocalizes with
the MMP-generated aggrecan neo-epitope VDIPEN in murine
antigen-induced arthritis. Proceedings of 44rd meeting
of the Orthopaedic Research society, march 16-19,
1998, New Orleans. 44:851, 1998
- 8
van Meurs J.B.J, van Lent P.L.E.M, Holthuysen A.E.M,
Stoop R, Singer I.I, Bayne E.K, Visco D, Mudgett J.S,
van den Berg W.B. Expression of the MMP-induced neoepitope
FVDIPEN is linked to sever cartilage damage: an essential
role for stromelysin in antigen-induced arthritis.
Proceedings of 44rd meeting of the Orthopaedic Research
society, march 16-19, 1998, New Orleans. 44:856 ,1998.
|
|
- 7
Bank R.A., Krikken M, Beekman B, Stoop R, Maroudas
A, Lafeber F.P.J.G, te Koppele J.M: A simplified measurement
of degraded collagen in tissues: application in healthy,
fibrillated and osteoarthitic cartilage. Matrix Biology:
16,233-243, 1997.
- 6
van Meurs J.B.J, van Lent P.L.E.M, Singer I.I, Bayne
E.K, Holthuysen A.E.M, Stoop R, van den Berg W.B.
Metalloproteinase and aggrecanase neo-epitopes in
murine arthritis. Proceedings of the 61st Annual meeting
of the American College of Rheumatology, Boston, MA.
Arthr Rheum., 40:s182, 1997.
- 5
Stoop R, Buma P, van der Kraan P.M, Poole A.R, and
van den Berg W.B: Collagen degradation during murine
experimental arthritis does not inevitably lead to
cartilage destruction. Proceedings of 43rd meeting
of the Orthopaedic Research society, february 9-13,
1997, San Francisco. 43:107, 1997.
- 4
Stoop R,
Buma P, van der Kraan P.M, Poole A.R, and van den
Berg W.B: Collagen degradation during murine experimental
arthritis does not inevitably lead to cartilage destruction.
Transactions of the combined 7th conference of the
European Orthopaedic Research Society, April 22-23,
1997, Barcelona 7:30, 1997.
- 3
Buma P,
Stoop R, Schreurs T and van Trigt M.A.J: Effects of
surgically anterior cruciate ligament transection
on rat articular cartilage. Transactions of the combined
7th conference of the European Orthopaedic Research
Society, April 22-23, 1997, Barcelona 7:149, 1997.
|
|
- 2
Balthazart
J, Stoop R, Foidart A, Harada N: Synergistic control
by androgens and estrogens of aromatase in the quail
brain. Neuroendocrin., 5(14):1729-1732, 1994.
- 1
Balthazart J, Stoop R, Foidart A, Granneman J.C.M,
Lambert J.G.D: Distribution and regulation of estrogen-2-hydroxylase
in the quail brain. Brain Res. Bull. 35(4):339-345,
1994.
|
|